Login
Home
Charts
Search
Watchlist
Products

Vivimed Labs Ltd

VIVIMEDLAB·NSE
₹5.28-1.86%Wed, 23 Sept '26 15:04
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Vivimed Labs Ltd

VIVIMEDLAB
NSE
₹5.28
-1.86%
|Wed, 23 Sept '26 15:04
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹44Cr
Close
Close Price
₹5.28
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
—
PS
Price To Sales
0.63
Revenue
Revenue
₹70Cr
Rev Gr TTM
Revenue Growth TTM
-39.80%
PAT Gr TTM
PAT Growth TTM
-451.99%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
353441392925372621211612
Growth YoY
Revenue Growth YoY%
-29.5-23.9-25.64.3-16.9-26.4-11.9-33.7-27.2-16.8-56.2-53.1
Expenses
ExpensesCr
3640406740253528222227152
Operating Profit
Operating ProfitCr
0-61-28-11-11-20-1-11-140
OPM
OPM%
-0.9-17.63.1-73.7-37.5-2.62.9-9.6-1.3-4.7-68.3-1,169.0
Other Income
Other IncomeCr
020800040006
Interest Expense
Interest ExpenseCr
111213-3300021211
Depreciation
DepreciationCr
5556447655512
PBT
PBTCr
-16-20-177-15-5-6-5-5-7-17-147
Tax
TaxCr
00-1100000000
PAT
PATCr
-16-20-165-15-5-6-6-5-7-17-147
Growth YoY
PAT Growth YoY%
29.87.812.3102.02.174.762.7-206.564.0-42.0-176.8-2,527.1
NPM
NPM%
-44.1-60.3-38.713.6-51.9-20.8-16.4-21.9-25.7-35.4-103.5-1,226.0
EPS
EPS₹
-1.9-2.5-1.90.6-1.8-0.6-0.7-0.7-0.7-0.9-2.0-17.2
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
353441392925372621211612
Growth YoY
Revenue Growth YoY%
-29.5-23.9-25.64.3-16.9-26.4-11.9-33.7-27.2-16.8-56.2-53.1
Expenses
ExpensesCr
3640406740253528222227152
Operating Profit
Operating ProfitCr
0-61-28-11-11-20-1-11-140
OPM
OPM%
-0.9-17.63.1-73.7-37.5-2.62.9-9.6-1.3-4.7-68.3-1,169.0
Other Income
Other IncomeCr
020800040006
Interest Expense
Interest ExpenseCr
111213-3300021211
Depreciation
DepreciationCr
5556447655512
PBT
PBTCr
-16-20-177-15-5-6-5-5-7-17-147
Tax
TaxCr
00-1100000000
PAT
PATCr
-16-20-165-15-5-6-6-5-7-17-147
Growth YoY
PAT Growth YoY%
29.87.812.3102.02.174.762.7-206.564.0-42.0-176.8-2,527.1
NPM
NPM%
-44.1-60.3-38.713.6-51.9-20.8-16.4-21.9-25.7-35.4-103.5-1,226.0
EPS
EPS₹
-1.9-2.5-1.90.6-1.8-0.6-0.7-0.7-0.7-0.9-2.0-17.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1,3801,3461,4621,1861,3151,05986123718714911670
Growth
Revenue Growth%
2.2-2.58.6-18.910.9-19.5-18.6-72.5-21.1-20.3-22.0-39.8
Expenses
ExpensesCr
1,1631,1141,0599741,1381,051832245374183129222
Operating Profit
Operating ProfitCr
217232403212177830-8-187-33-13-152
OPM
OPM%
15.717.327.517.913.50.83.5-3.4-100.1-22.4-11.2-217.8
Other Income
Other IncomeCr
61181023810111046
Interest Expense
Interest ExpenseCr
798266796759544036234
Depreciation
DepreciationCr
6661585667675618108202026
PBT
PBTCr
781002868666-109-70-65-331-46-32-176
Tax
TaxCr
51673109023-2000
PAT
PATCr
72842147657-109-72-68-329-45-32-176
Growth
PAT Growth%
8.516.1155.7-64.4-24.6-290.234.15.9-385.686.229.7-452.1
NPM
NPM%
5.26.214.66.44.4-10.3-8.3-28.5-175.6-30.5-27.5-252.1
EPS
EPS₹
8.92.125.99.27.0-13.2-9.4-8.2-39.6-5.5-3.9-21.1
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
1,3801,3461,4621,1861,3151,05986123718714911670
Growth
Revenue Growth%
2.2-2.58.6-18.910.9-19.5-18.6-72.5-21.1-20.3-22.0-39.8
Expenses
ExpensesCr
1,1631,1141,0599741,1381,051832245374183129222
Operating Profit
Operating ProfitCr
217232403212177830-8-187-33-13-152
OPM
OPM%
15.717.327.517.913.50.83.5-3.4-100.1-22.4-11.2-217.8
Other Income
Other IncomeCr
61181023810111046
Interest Expense
Interest ExpenseCr
798266796759544036234
Depreciation
DepreciationCr
6661585667675618108202026
PBT
PBTCr
781002868666-109-70-65-331-46-32-176
Tax
TaxCr
51673109023-2000
PAT
PATCr
72842147657-109-72-68-329-45-32-176
Growth
PAT Growth%
8.516.1155.7-64.4-24.6-290.234.15.9-385.686.229.7-452.1
NPM
NPM%
5.26.214.66.44.4-10.3-8.3-28.5-175.6-30.5-27.5-252.1
EPS
EPS₹
8.92.125.99.27.0-13.2-9.4-8.2-39.6-5.5-3.9-21.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
161616171717171717171717
Reserves
ReservesCr
47950571888560249341534823-22-52-227
Current Liabilities
Current LiabilitiesCr
801897817790889770341373424410408448
Non Current Liabilities
Non Current LiabilitiesCr
538561510365496605517528532546548516
Total Liabilities
Total LiabilitiesCr
1,8982,0442,0622,3942,3292,2101,2891,266995951921753
Current Assets
Current AssetsCr
9921,1331,0941,2821,231975529507339343328168
Non Current Assets
Non Current AssetsCr
9079119681,1121,0991,234761759656608593585
Total Assets
Total AssetsCr
1,8982,0442,0622,3942,3292,2101,2891,266995951921753
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
161616171717171717171717
Reserves
ReservesCr
47950571888560249341534823-22-52-227
Current Liabilities
Current LiabilitiesCr
801897817790889770341373424410408448
Non Current Liabilities
Non Current LiabilitiesCr
538561510365496605517528532546548516
Total Liabilities
Total LiabilitiesCr
1,8982,0442,0622,3942,3292,2101,2891,266995951921753
Current Assets
Current AssetsCr
9921,1331,0941,2821,231975529507339343328168
Non Current Assets
Non Current AssetsCr
9079119681,1121,0991,234761759656608593585
Total Assets
Total AssetsCr
1,8982,0442,0622,3942,3292,2101,2891,266995951921753

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1401545821422805672835-24-28
Investing Cash Flow
Investing Cash FlowCr
-107-190-68-164-89-196404-16-528-5-1
Financing Cash Flow
Financing Cash FlowCr
-424135186-33872-1,015-10-34-65-6
Net Cash Flow
Net Cash FlowCr
-842544-5-44-441-3-2-11
Free Cash Flow
Free Cash FlowCr
1695-11-142333-331,0841130-26-6
CFO To PAT
CFO To PAT%
195.0184.227.128.1735.9-72.9-789.1-40.7-10.852.85.5-4.4
CFO To EBITDA
CFO To EBITDA%
64.866.414.410.1238.3981.61,910.6-341.7-18.971.813.4-5.0
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1401545821422805672835-24-28
Investing Cash Flow
Investing Cash FlowCr
-107-190-68-164-89-196404-16-528-5-1
Financing Cash Flow
Financing Cash FlowCr
-424135186-33872-1,015-10-34-65-6
Net Cash Flow
Net Cash FlowCr
-842544-5-44-441-3-2-11
Free Cash Flow
Free Cash FlowCr
1695-11-142333-331,0841130-26-6
CFO To PAT
CFO To PAT%
195.0184.227.128.1735.9-72.9-789.1-40.7-10.852.85.5-4.4
CFO To EBITDA
CFO To EBITDA%
64.866.414.410.1238.3981.61,910.6-341.7-18.971.813.4-5.0

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
59667486258619360131120554444
Price To Earnings
Price To Earnings
8.38.14.07.53.4-0.3
Price To Sales
Price To Sales
0.40.50.60.50.10.10.10.50.30.60.6
Price To Book
Price To Book
1.21.31.20.70.30.10.30.439.2-0.2-0.2
EV To EBITDA
EV To EBITDA
6.75.64.15.74.8110.915.2-58.5-2.3-2.9-2.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.838.449.141.941.033.237.423.6-61.641.138.3
OPM
OPM%
15.717.327.517.913.50.83.5-3.4-100.1-22.4-11.2-217.8-217.8
NPM
NPM%
5.26.214.66.44.4-10.3-8.3-28.5-175.6-30.5-27.5-252.1-252.1
ROCE
ROCE%
11.415.322.510.39.7-3.6-2.1-3.5-70.5-11.7-8.5-92.2-92.2
ROE
ROE%
14.616.129.18.49.3-21.4-16.7-18.6-833.4832.290.983.883.8
ROA
ROA%
3.84.110.43.22.5-4.9-5.6-5.3-33.0-4.8-3.5-23.4-23.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
59667486258619360131120554444
Price To Earnings
Price To Earnings
8.38.14.07.53.4-0.3
Price To Sales
Price To Sales
0.40.50.60.50.10.10.10.50.30.60.6
Price To Book
Price To Book
1.21.31.20.70.30.10.30.439.2-0.2-0.2
EV To EBITDA
EV To EBITDA
6.75.64.15.74.8110.915.2-58.5-2.3-2.9-2.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.838.449.141.941.033.237.423.6-61.641.138.3
OPM
OPM%
15.717.327.517.913.50.83.5-3.4-100.1-22.4-11.2-217.8-217.8
NPM
NPM%
5.26.214.66.44.4-10.3-8.3-28.5-175.6-30.5-27.5-252.1-252.1
ROCE
ROCE%
11.415.322.510.39.7-3.6-2.1-3.5-70.5-11.7-8.5-92.2-92.2
ROE
ROE%
14.616.129.18.49.3-21.4-16.7-18.6-833.4832.290.983.883.8
ROA
ROA%
3.84.110.43.22.5-4.9-5.6-5.3-33.0-4.8-3.5-23.4-23.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Vivimed Labs Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/pv6zi20c2vgvbl55ct5xzbgl.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/fji8wrduxo6xmpt46pyi34ff.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/yjpyb7sl13h7wuq6tscyvwhc.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/pulxv7vj9f7o0y2em0lmo64n.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/76im9g7e74it9jie8mmeo5ha.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/effg0tldntiw7m577k7zrsrr.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/0gl2827nkph6l2yqrp7axeg8.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/eozpijpdel4geneuk28s0lsn.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/o9ud30iuhwg27kqycnd7fmrz.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/qzyjxo8dhk73vudpptkvgj1j.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/l5bpvz9jbgcbvucl0e6ms66c.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/kvrkvenaeore7azcpikcft6m.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/e9ixtro4szae7kqu21qs8r2g.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/og32zynvza4iymq0vxvjv87k.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies